Glooko Mobile App Now Free For All People with Diabetes!

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Glooko, the leader in diabetes data management, announced today its
mobile app (available for Android
and iOS) is now free* for any person with diabetes. Previously,
there was a subscription fee for individuals not sponsored through their
provider, health plan, or employer. The mobile app can help users
effectively self-manage their condition through glucose tracking,
insights delivery and by correlating food, exercise and medication data
to create actionable insights. For healthcare providers who use Glooko
for remote monitoring, their entire patient population now will be
available for them to provide this service. Glooko remote monitoring
programs have been demonstrated to help participants improve outcomes,
including improving average blood glucose by 12% and reducing the
occurrence of hyperglycemia by 15%**; this change allows a broader
population to experience these clinical benefits.

Remote monitoring also offers providers the ability to have efficient
in-clinic appointments, as patients can sync their device data at home
rather than doing so in the office, as well as access new revenue
streams via newly available CPT codes for remote patient monitoring.
These codes provide reimbursement for key tasks required to remotely
monitor patients, including training patients, collecting and monitoring
remotely synced data, and communicating with patients about changes to
their treatment plan based on the data they sync remotely.

“Glooko strives to improve the lives of people with diabetes by
providing actionable insights to inform care decisions,” said Russ
Johannesson, CEO of Glooko. “I am thrilled we are removing the
subscription fee for users of the mobile app - this will allow anyone
who wants to use Glooko for self-management to be able to do so. I am
also excited about the ability for providers to remotely monitor larger
patient populations. Diabetes is a very complicated, data-intensive
condition; more frequent support for patients is critical in helping
them better manage their diabetes.”

All features of the Glooko mobile app will be available in the free
version, including the ability to sync data from compatible
blood glucose meters, insulin pumps, continuous glucose monitors, and
fitness trackers, the ability to log food (including via the recently
released barcode
scanner), medication, and activity, access to interactive charts and
graphs, and the ability to easily send reports to providers and care
teams. Glooko also announced today the support for the first implantable
long term glucose sensor, the Senseonics Eversense® Continuous Glucose
Monitoring System (CGM), available in the free app. Users of the
Eversense CGM simply need to connect their Eversense account to Glooko,
and their Eversense data will be available along with blood glucose,
insulin, food, and any other information logged.

*one-time hardware costs may apply

**improvement after three months for users in Glooko remote monitoring
programs with coaching

About Glooko

Glooko’s universal diabetes software products provide insights to
improve outcomes for people with diabetes and their care teams. The
Glooko product suite contains the diasend® and Glooko diabetes
management solutions, which integrate with many of the leading EHR
systems used today. Both systems sync data from 190+ of the world’s most
popular diabetes devices, major fitness and activity trackers and
supplies personalized, timely patient data such as glucose level, food,
insulin, medications, blood pressure and weight data. Trusted by the
world’s leaders in diabetes care, our solutions cover more than 2.2
million people with diabetes and are used in 9,000 clinic locations in
23 countries across 15 languages. Learn more by visiting www.glooko.com.